SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-19-007742
Filing Date
2019-04-26
Accepted
2019-04-26 17:27:07
Documents
4
Period of Report
2019-06-20
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10001182x1_def14a.htm DEF 14A 860339
2 nc10001182x1_chart1.jpg GRAPHIC 75334
3 nc10001182x1_proxycard01.jpg GRAPHIC 1059309
4 nc10001182x1_proxycard02.jpg GRAPHIC 761724
  Complete submission text file 0001140361-19-007742.txt   3275934
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38470 | Film No.: 19772963
SIC: 2834 Pharmaceutical Preparations